Skip to content
WorldBrand.AI

RAPT Therapeutics

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2019

    RAPT and Hanmi announce FLX475 Asia license and collaboration

    RAPT Therapeutics and Hanmi Pharmaceutical announced a license and collaboration agreement for FLX475 in Asia. Hanmi received an exclusive license to develop and commercialize the cancer treatment in South Korea and China, including Taiwan and Hong Kong, and will conduct a Phase 2 trial in Korea and China.

    Source